Sign in
bf/NASDAQ:ARDS_icon.png

NASDAQ:ARDS

Aridis Pharmaceuticals, Inc.

  • Stock

USD

Market Cap

2.94M

Beta: 0.99

Volume Today

174.90K

Avg: 997.59K

PE Ratio

−4.42

PFCF: −0.20

OverviewAnalysisFinancialsFilingspeopleOwnershipAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Excel Tearsheet
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
asset turnover
0.10
-
0.03
67.74%
0.09
168.53%
0.04
58.10%
0.07
81.02%
cash conversion cycle
-117.64
-
cash per share
2.83
-
3.18
12.58%
7.70
142.17%
2.47
67.92%
0.90
63.66%
1.63
81.10%
0.26
84.03%
company equity multiplier
1.64
-
2.32
41.52%
1.20
48.12%
7.69
540.28%
-1.74
122.64%
-1.90
9.06%
-0.61
68.07%
days of inventory outstanding
days of payables outstanding
128.42
-
days of sales outstanding
10.78
-
219.77
-
147.50
32.88%
134.32
8.94%
dividend yield
0.04
-
0.14
-
ebit per revenue
-3.47
-
-22.95
560.53%
-8.75
61.89%
-28.46
225.36%
-22.40
21.29%
ebt per ebit
1.07
-
1.25
16.94%
0.92
26.63%
1.02
11.33%
1.00
2.30%
0.99
0.88%
1.01
2.47%
effective tax rate
-0.06
-
-0.20
212.25%
-0.11
44.84%
0.02
121.28%
0.02
20.83%
0.02
13.90%
-0.01
158.95%
enterprise value multiple
-10.44
-
-5.33
48.91%
-0.41
92.24%
-0.58
39.04%
-2.15
273.33%
-0.33
84.68%
-0.79
140.95%
fixed asset turnover
58.18
-
1.15
98.03%
2.17
89.17%
1.02
53.17%
0.79
21.75%
free cash flow per share
-0.77
-
-2.31
198.97%
-7.93
242.69%
-0.99
87.57%
-2.27
130.74%
-1.91
16.02%
-1.56
18.52%
gross profit margin
0.15
-
1
563.45%
1
0%
1
0%
1
0%
interest coverage
-21.54
-
-57.42
-
178.41
-
-79.35
144.47%
inventory turnover
long term debt to capitalization
-0.03
-
-0.60
1,722.07%
-0.06
90.59%
net income per ebt
1
-
1
0%
1
0%
0.98
2.34%
0.98
0.50%
0.98
0.26%
1.01
3.43%
net profit margin
-3.71
-
-28.67
672.40%
-8.02
72.03%
-28.36
253.74%
-21.92
22.72%
operating cash flow per share
-0.77
-
-2.23
188.24%
-7.71
246.64%
-0.96
87.49%
-2.23
131.52%
-1.87
16.44%
-1.55
16.87%
operating cycle
10.78
-
operating profit margin
-3.47
-
-22.95
560.53%
-8.75
61.89%
-28.46
225.36%
-22.40
21.29%
payables turnover
2.84
-
pretax profit margin
-3.71
-
-28.67
672.40%
-8.02
72.03%
-29.04
262.22%
-22.33
23.10%
price fair value
7.45
-
8.97
20.45%
1.33
85.21%
10.35
680.60%
-6.41
161.93%
-2.03
68.34%
-0.91
54.95%
receivables turnover
33.87
-
1.66
-
2.47
49.00%
2.72
9.81%
return on assets
-0.37
-
-0.93
149.18%
-0.70
24.90%
-1.04
48.21%
-1.45
39.90%
-1.58
8.82%
-2.09
32.61%
return on capital employed
-0.39
-
-0.85
116.36%
-0.92
8.21%
-3.37
267.49%
3.06
190.82%
6.67
118.09%
1.35
79.75%
return on equity
-0.61
-
-2.16
252.63%
-0.84
61.04%
-7.97
848.99%
2.52
131.67%
3.00
18.68%
1.27
57.65%
total debt to capitalization
0.09
-
-0.09
-
-0.74
719.02%
-0.34
53.93%

All numbers in USD (except ratios and percentages)